logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

The Public Financing Of Pharmaceuticals An Economic Approach Illustrated Edition Jaume Puigjunoy

  • SKU: BELL-928894
The Public Financing Of Pharmaceuticals An Economic Approach Illustrated Edition Jaume Puigjunoy
$ 31.00 $ 45.00 (-31%)

4.7

56 reviews

The Public Financing Of Pharmaceuticals An Economic Approach Illustrated Edition Jaume Puigjunoy instant download after payment.

Publisher: E. Elgar
File Extension: PDF
File size: 1.36 MB
Pages: 272
Author: Jaume Puig-Junoy
ISBN: 9781845420888, 1845420888
Language: English
Year: 2005
Edition: illustrated edition

Product desciption

The Public Financing Of Pharmaceuticals An Economic Approach Illustrated Edition Jaume Puigjunoy by Jaume Puig-junoy 9781845420888, 1845420888 instant download after payment.

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability. The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries, and policymakers.

Related Products